Alembic Pharmaceuticals reports 30% rise in Q3 consolidated net profit

22 Jan 2019 Evaluate

Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2018.

The company has reported a rise of 31.86% in its net profit at Rs 138.51 crore for the quarter under review as compared to Rs 105.04 crore for the same quarter in the previous year. Total income of the company increased by 20.24% at Rs 908.08 crore for Q3FY19 as compared Rs 755.23 crore for the corresponding quarter previous year. 

On the consolidated basis, the company has reported a rise of 30.04% in its net profit at Rs 169.83 crore for the quarter under review as compared to Rs 130.60 crore for the same quarter in the previous year. Total income of the company increased by 21.58% at Rs 1021.67 crore for Q3FY19 as compared Rs 840.34 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

944.20 -21.00 (-2.18%)
18-Apr-2024 11:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1538.60
Dr. Reddys Lab 6101.60
Cipla 1376.50
Zydus Lifesciences 945.05
Lupin 1625.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.